2024
Understanding chronic pain in Neurofibromatosis Type 1 using the Neurofibromatosis Pain Module (NFPM)
Buono F, Larkin K, Zempsky W, Grau L, Martin S. Understanding chronic pain in Neurofibromatosis Type 1 using the Neurofibromatosis Pain Module (NFPM). American Journal Of Medical Genetics Part A 2024, 194: e63541. PMID: 38234177, DOI: 10.1002/ajmg.a.63541.Peer-Reviewed Original ResearchNeurofibromatosis type 1Chronic painImpact of CPPain modulationPain regionsModerate pain severityType 1Autosomal dominant genetic disorderCross-sectional studyQuality of lifeDominant genetic disorderMedical providersPain severitySensitive clinical measureDaily functioningClinical measuresPainEffective treatmentGenetic disordersNeurofibromatosisClinical assessmentMultiple domainsAdultsQuantitative responseProviders
2013
Drug users in Hanoi, Vietnam: factors associated with membership in community-based drug user groups
Hayes-Larson E, Grau LE, Khoshnood K, Barbour R, Khuat OT, Heimer R. Drug users in Hanoi, Vietnam: factors associated with membership in community-based drug user groups. Harm Reduction Journal 2013, 10: 33. PMID: 24268108, PMCID: PMC4176489, DOI: 10.1186/1477-7517-10-33.Peer-Reviewed Original ResearchConceptsDrug user groupsResult of membershipDomains of knowledgeInjection-related harmsLongitudinal studyGreater historyDrug usePost-hoc evaluationMembershipLow statistical powerFurther longitudinal studiesQuality of lifeUser groupsFaceHigh levelsPeersMore attentionHealth issuesMultivariate modelBeingHarm reductionDrug usersKnowledge variablesHarmVariables
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply